Bridget S. Wilson
University of Colorado Denver
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bridget S. Wilson.
Archive | 1997
Janet M. Oliver; Janet R. Pfeiffer; Bridget S. Wilson
Mast cells, basophils and RBL-2H3 rat tumor mast cells are activated by treatments that crosslink their high affinity IgE receptor, FceRI. Receptor crosslinking causes degranulation, releasing inflammatory agents that initiate the immediate hypersensitivity diseases including allergy, asthma and anaphylaxis. Receptor crosslinking also stimulates the production of lipid mediators that amplify the immediate inflammatory response and of cytokines that maintain inflammation through the recruitment and activation of other pro-inflammatory cells. Additionally, FceRI crosslinking induces a series of immediate and dramatic changes in the membrane, cytoskeletal and adhesive properties of basophils and mast cells that are the subject of this chapter.
Frontiers in Optics 2010/Laser Science XXVI (2010), paper LWL3 | 2010
James H. Werner; M. Lisa Phipps; Peter M. Goodwin; Patrick J. Cutler; Diane S. Lidke; Bridget S. Wilson
We have developed a microscope system that uses active feed-back to follow individual quantum dot labeled proteins moving in three dimensions in live cells at μm/s transport velocities with 100 picoseconds temporal resolution.
Archive | 1999
Bridget S. Wilson; Timothy Graham; Janet R. Pfeiffer; Janet M. Oliver
In mast cells and basophils, cross-linking the high-affinity IgE receptor, FceRI, leads to the secretion of histamine and other granule constituents, to changes in adhesive properties, cell shape, and surface topography, and to the synthesis of lipid mediators of inflammation and of cytokines. Key features of this signaling cascade were summarized by contributors to an earlier volume1 and are updated in other chapters in this volume. In brief, cross-linking IgE-bound receptors with multivalent ligands activates receptor-associated Lyn, a member of the Src tyrosine kinase family whose principal mast cell substrates are immunoreceptor tyrosine-based activation motifs (ITAMs) found in the FceRI γ- and β-subunit cytoplasmic domains.2–4 Lyn-mediated receptor subunit phosphorylation in turn permits the recruitment and activation of Syk tyrosine kinase5 and the phosphorylation of multiple protein substrates.6
Blood | 2008
Bridget S. Wilson; Xiangbing Meng; Tomas Mazel; Cheryl L. Willman; Susan Atlas; Richard Harvey; I.-Ming Chen; Stephen P. Hunger; Janet M. Oliver; Stuart S. Winter
Archive | 1998
Janet M. Oliver; Bridget S. Wilson; Enrique Ortega
Archive | 2016
Bridget S. Wilson; Stuart S. Winter; Michael Frank Erasmus; Michael Horowitz
Archive | 2013
Yanli Liu; Benjamin Schudel; Anup K. Singh; Carl C. Hayden; William S. Hlavacek; Avanika Mahajan; Diane S. Lidke; Bridget S. Wilson
Archive | 2011
Yanli Liu; Anup K. Singh; Bridget S. Wilson; Janet M. Oliver
Archive | 2010
Jerilyn A. Timlin; Kathrin Spendier; Amanda Carroll-Portillo; Keith A. Lidke; Bridget S. Wilson; W.M. Kenkre; James L. Thomas
Archive | 2010
M. Oliver; Clifford Qualls; Bridget S. Wilson; Julie D. J. Bard; Christy A. Tarleton; Lama Youssef; Mark Schuyler; Laura Gilmartin